NCT02948829View on ClinicalTrials.gov

Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

October 16, 2017

Study Completion Date

December 14, 2020

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

TDV

TDV SC injection.

Trial Locations (2)

1781

Research Institute for Tropical Medicine, City of Muntinlupa

Unknown

CEVAXIN, Panama City

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY